Biotech Stock Roundup: ZGNX's Acquisition News, REGN, BLUE's Updates & More

Published on January 20, 2022

Regulatory and other pipeline updates from Zogenix (ZGNX) and Regeneron (REGN) are among a few key highlights from the biotech sector during the past week.

Continue reading on website
Other news

Rollins (ROL) to Report Q4 Earnings: What's in the Cards?

January 20, 2022
Rollins' (ROL) fourth-quarter 2021 earnings and revenues are expected to have increased year over year.

Nasdaq in Correction: ETF Strategies to Play

January 20, 2022
The Nasdaq, heavy on technology and growth stocks, is now off 10% from its November record due to rising rate worries, Play these ETFs instead.